keyword
MENU ▼
Read by QxMD icon Read
search

Leadless pacing

keyword
https://www.readbyqxmd.com/read/28529181/leadless-cardiac-pacemakers-current-status-of-a-modern-approach-in-pacing
#1
REVIEW
Skevos Sideris, Stefanos Archontakis, Polychronis Dilaveris, Konstantinos A Gatzoulis, Konstantinos Trachanas, Ilias Sotiropoulos, Petros Arsenos, Dimitrios Tousoulis, Ioannis Kallikazaros
Since the first transvenous pacemaker implantation, that took place 50 years ago, important progress has been achieved in pacing technology. Consequently, today, more than 700,000 pacemakers are implanted annually worldwide. However, conventional pacemakers' implantation carries a non-negligible risk of periprocedural and long-term complications associated with the transvenous leads and pacemaker pocket. Recently, Leadless Pacing Systems have emerged as a therapeutic alternative to conventional pacing systems providing therapy for patients with bradyarrhythmias, while eliminating potential transvenous leads and pacemaker pocket related complications...
May 18, 2017: Hellenic Journal of Cardiology: HJC, Hellēnikē Kardiologikē Epitheōrēsē
https://www.readbyqxmd.com/read/28502871/a-leadless-pacemaker-in-the-real-world-setting-the-micra-transcatheter-pacing-system-post-approval-registry
#2
Paul R Roberts, Nicolas Clementy, Faisal Al Samadi, Christophe Garweg, Jose Luis Martinez-Sande, Saverio Iacopino, Jens Brock Johansen, Xavier Vinolas Prat, Robert Kowal, Didier Klug, Lluis Mont, Jan Steffel, Shelby Li, Dirk Van Osch, Mikhael F El-Chami
BACKGROUND: First-in-man studies of leadless pacemakers have demonstrated high implant success rates, and safety and efficacy objectives were achieved. Outside of the investigational setting, there are particular concerns over cardiac effusion/perforation, device dislodgement, infection, telemetry, and battery issues. OBJECTIVE: The acute performance of the Micra transcatheter pacemaker from a worldwide post-approval registry is reported. METHODS: The registry is an ongoing prospective single-arm observational study designed to assess the safety and effectiveness of Micra in the post-approval setting...
May 11, 2017: Heart Rhythm: the Official Journal of the Heart Rhythm Society
https://www.readbyqxmd.com/read/28496929/management-of-patients-with-atrial-fibrillation-focus-on-treatment-options
#3
REVIEW
Pawel Matusik, Jacek Lelakowski, Barbara Malecka, Jacek Bednarek, Remigiusz Noworolski
Atrial fibrillation (AF) is leading cardiac arrhythmia with important clinical implications. Its diagnosis is usually made on the basis on 12-lead ECG or 24-hour Holter monitoring. More and more clinical evidence supports diagnostic use of cardiac event recorders and cardiovascular implantable electronic devices (CIED). Treatment options in patients with atrial fibrillation are extensive and are based on chosen rhythm and/or rate control strategy. The use and selected contraindications to AF related pharmacotherapy, including anticoagulants are shown...
October 2016: Journal of Atrial Fibrillation
https://www.readbyqxmd.com/read/28491800/reply-to-the-editor-regarding-cardiac-resynchronization-therapy-in-coronary-sinus-atresia-delivered-using-leadless-endocardial-pacing
#4
(no author information available yet)
No abstract text is available yet for this article.
March 2017: HeartRhythm Case Reports
https://www.readbyqxmd.com/read/28491799/to-the-editor-cardiac-resynchronization-therapy-in-coronary-sinus-atresia-delivered-using-leadless-endocardial-pacing
#5
Berry M van Gelder, Frank A Bracke
No abstract text is available yet for this article.
March 2017: HeartRhythm Case Reports
https://www.readbyqxmd.com/read/28491727/cardiac-resynchronization-therapy-in-coronary-sinus-atresia-delivered-using-leadless-endocardial-pacing
#6
Dewi E Thomas, Nicholas M Child, W Andrew Owens, Nicholas J Linker, Simon A James, Andrew J Turley
No abstract text is available yet for this article.
September 2016: HeartRhythm Case Reports
https://www.readbyqxmd.com/read/28489502/advances-in-cardiac-pacing-and-defibrillation
#7
Kristin Ellison, Parikshit S Sharma, Richard Trohman
There have been many milestones in the evolution of cardiac implantable electronic devices (CIEDs) over the past few decades. Along with advancements in the field, new challenges have arisen. The ability to pace the right ventricular was the original breakthrough in the late 1950s, however adverse structural and clinical effects of long-term pacing induced dyssynchrony have recently become evident. Biventricular pacing has provided a viable option to help mitigate dyssynchrony, but has only proved to be beneficial for selective patients (primarily left bundle branch block and QRS duration ≥ 150 ms with depressed left ventricular (LV) function)...
May 10, 2017: Expert Review of Cardiovascular Therapy
https://www.readbyqxmd.com/read/28449773/leadless-left-ventricular-pacing-another-step-toward-improved-crt-response
#8
EDITORIAL
Wilfried Mullens, Petra Nijst
No abstract text is available yet for this article.
May 2, 2017: Journal of the American College of Cardiology
https://www.readbyqxmd.com/read/28439940/impact-of-operator-experience-and-training-strategy-on-procedural-outcomes-with-leadless-pacing-insights-from-the-micra-transcatheter-pacing-study
#9
Mikhael El Chami, Robert C Kowal, Kyoko Soejima, Philippe Ritter, Gabor Z Duray, Petr Neuzil, Lluis Mont, Alexander Kypta, Venkata Sagi, J Harrison Hudnall, Kurt Stromberg, Dwight Reynolds
BACKGROUND: Leadless pacemaker systems have been designed to avoid the need for a pocket and transvenous lead. However, delivery of this therapy requires a new catheter-based procedure. This study evaluates the role of operator experience and different training strategies on procedural outcomes. METHODS: A total of 726 patients underwent implant attempt with the Micra transcatheter pacing system (TPS) by 94 operators trained in a teaching laboratory using a simulator, cadaver, and large animal models (lab training) or locally at the hospital with simulator/demo model and proctorship (hospital training)...
April 24, 2017: Pacing and Clinical Electrophysiology: PACE
https://www.readbyqxmd.com/read/28396380/permanent-leadless-cardiac-pacemaker-therapy-a-comprehensive-review
#10
REVIEW
Fleur V Y Tjong, Vivek Y Reddy
A new technology, leadless pacemaker therapy, was recently introduced clinically to address lead- and pocket-related complications in conventional transvenous pacemaker therapy. These leadless devices are self-contained right ventricular single-chamber pacemakers implanted by using a femoral percutaneous approach. In this review of available clinical data on leadless pacemakers, early results with leadless devices are compared with historical results with conventional single-chamber pacing. Both presently manufactured leadless pacemakers show similar complications, which are mostly related to the implant procedure: cardiac perforation, device dislocation, and femoral vascular access site complications...
April 11, 2017: Circulation
https://www.readbyqxmd.com/read/28377192/sudden-cardiac-death-new-approaches-for-implantable-cardioverter-defibrillators-icds
#11
Riccardo Cappato, Hussam Ali
The implantable cardioverter-defibrillator (ICD) has shown its superiority to anti-arrhythmic drugs in the prevention of sudden cardiac death. However, the conventional transvenous ICDs are still associated with substantial risks and comorbidities mainly related to the transvenous leads. The recent advent of an entirely sub-cutaneous ICD (S-ICD) represents an important progress in the defibrillation technology towards a less invasive approach. Clinical data are growing regarding the safety and efficacy of S-ICD in prevention of sudden cardiac death in selected patients without pacing indications...
March 18, 2017: International Journal of Cardiology
https://www.readbyqxmd.com/read/28365650/advancements-in-pacemaker-technology-the-leadless-device
#12
Mary Leier
Leadless pacemakers will most likely be the future of cardiac pacing. Leadless pacing employs a single-chamber system to pace only the right ventricle and is fully self-contained, which eliminates the need for leads. These systems, implanted by using a transcatheter sheath, are indicated for patients who need right ventricular pacing only. These devices enable patients to avoid lead-related complications, from lead fracture to extraction challenges, as well as pocket-related complications such as infection and disfigurement...
April 2017: Critical Care Nurse
https://www.readbyqxmd.com/read/28192209/a-new-alara-keeping-leadless-pacing-thresholds-as-low-as-reasonably-achievable
#13
EDITORIAL
Joseph E Marine
No abstract text is available yet for this article.
May 2017: Heart Rhythm: the Official Journal of the Heart Rhythm Society
https://www.readbyqxmd.com/read/28192207/long-term-performance-of-a-transcatheter-pacing-system-12-month-results-from-the-micra-transcatheter-pacing-study
#14
Gabor Z Duray, Philippe Ritter, Mikhael El-Chami, Calambur Narasimhan, Razali Omar, Jose M Tolosana, Shu Zhang, Kyoko Soejima, Clemens Steinwender, Leonardo Rapallini, Aida Cicic, Dedra H Fagan, Shufeng Liu, Dwight Reynolds
BACKGROUND: Early performance of the Micra transcatheter pacemaker from the global clinical trial reported a 99.2% implant success rate, low and stable pacing capture thresholds, and a low (4.0%) rate of major complications up to 6 months. OBJECTIVE: The purpose of this report was to describe the prespecified long-term safety objective of Micra at 12 months and electrical performance through 24 months. METHODS: The Micra Transcatheter Pacing Study was a prospective single-arm study designed to assess the safety and efficacy of the Micra VVIR leadless/intracardiac pacemaker...
May 2017: Heart Rhythm: the Official Journal of the Heart Rhythm Society
https://www.readbyqxmd.com/read/28111349/long-term-outcomes-in-leadless-micra-transcatheter-pacemakers-with-elevated-thresholds-at-implantation-results-from-the-micra-transcatheter-pacing-system-global-clinical-trial
#15
Jonathan P Piccini, Kurt Stromberg, Kevin P Jackson, Verla Laager, Gabor Z Duray, Mikhael El-Chami, Christopher R Ellis, John Hummel, D Randy Jones, Robert C Kowal, Calambur Narasimhan, Razali Omar, Philippe Ritter, Paul R Roberts, Kyoko Soejima, Shu Zhang, Dwight Reynolds
BACKGROUND: Device repositioning during Micra leadless pacemaker implantation may be required to achieve optimal pacing thresholds. OBJECTIVE: The purpose of this study was to describe the natural history of acute elevated Micra vs traditional transvenous lead thresholds. METHODS: Micra study VVI patients with threshold data (at 0.24 ms) at implant (n = 711) were compared with Capture study patients with de novo transvenous leads at 0.4 ms (n = 538)...
May 2017: Heart Rhythm: the Official Journal of the Heart Rhythm Society
https://www.readbyqxmd.com/read/28040461/the-micra-leadless-transcatheter-pacemaker-implantation-and-mid-term-follow-up-results-in-a-single-center
#16
José Luis Martínez-Sande, Javier García-Seara, Moisés Rodríguez-Mañero, Xesús Alberte Fernández-López, Laila González-Melchor, Alfredo Redondo-Diéguez, Rocío González-Ferreiro, José Ramón González-Juanatey
INTRODUCTION AND OBJECTIVES: Currently, studies on the leadless pacemaker (Micra) have mostly been limited to clinical trials with less than 6 months' follow-up and they often fail to reflect real population outcomes. We sought to evaluate electrical parameters at implantation and chronologically during follow-up, as well as the safety of this new technique. METHODS: This prospective, observational study included 30 consecutive patients, all ≥ 65 years, with an indication for single-chamber pacemaker implantation...
December 28, 2016: Revista Española de Cardiología
https://www.readbyqxmd.com/read/27908571/selection-of-the-best-of-2016-on-cardiac-pacing-leadless-pacing
#17
LETTER
María Luisa Fidalgo Andrés, Lluis Mont Girbau, Diego Lorente Carreño, Marta Pombo Jiménez, Oscar Cano Pérez, Julia Martín Fernández
No abstract text is available yet for this article.
January 2017: Revista Española de Cardiología
https://www.readbyqxmd.com/read/27889044/leadless-pacemakers
#18
REVIEW
Mikhael F El-Chami, Faisal M Merchant, Angel R Leon
Leadless pacing is an emerging technology with the potential to significantly improve outcomes associated with the need for long-term pacing. Specifically, the major advantage of leadless systems is abolishing the need for transvenous leads and subcutaneous pockets, both of which account for most adverse events associated with traditional pacemakers. Two leadless pacemakers are currently available: the Nanostim (leadless cardiac pacemaker [LCP]) device (St. Jude Medical, Sylmar, California) and the Micra Transcatheter pacing system (Medtronic, Minneapolis, Minnesota)...
January 1, 2017: American Journal of Cardiology
https://www.readbyqxmd.com/read/27861115/leadless-cardiac-pacing-what-primary-care-providers-and-non-ep-cardiologists-should-know
#19
REVIEW
Erich L Kiehl, Daniel J Cantillon
Over the last 50 years, the use of transvenous pacemakers has been constrained by long-term complications that affect more than 1 in 10 patients, largely attributable to the endovascular leads and surgical pocket. Leadless cardiac pacing involves a self-contained pacemaker deployed directly into the heart without a lead or incisional access. The procedure has shown promise, eliminating pocket-related complications. Other advantages include postprocedural shoulder mobility and the ability to drive, shower, and bathe...
November 2016: Cleveland Clinic Journal of Medicine
https://www.readbyqxmd.com/read/27855290/transcatheter-leadless-cardiac-pacing-the-new-alternative-solution
#20
Antoine Da Costa, Amandine Axiotis, Cécile Romeyer-Bouchard, Loucif Abdellaoui, Zahi Afif, Jean Baptiste Guichard, Antoine Gerbay, Karl Isaaz
INTRODUCTION: A lack of information about the feasibility and safety of leadless pacemaker (LPMs) exists in a fragile population of patients with limited venous anatomy access or conventional pacemaker (PM) contraindication. Accordingly, the goal of this prospective observational study was to report our experience with this new leadless technology in a subset of patients with contraindication or limited venous access. METHODS AND RESULTS: Between May 2015 and July 2016, 14 patients were consecutively included...
January 15, 2017: International Journal of Cardiology
keyword
keyword
107110
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"